Table III.
Author | Number of CEA | 30-day stroke (%) | Mean F/U | Recurrent stenosis |
---|---|---|---|---|
PTFE | ||||
AbuRahma et al.17,a | 100 | 2 | 21 | >70% = 11% at 36 months |
Grego et al.22,a | 80 | 1 | 45 | >50% = 9.8% at 30 months |
AbuRahma et al.18 | 200 | 1 | 21 | >70% = 6% at 48 months |
Gonzalez-Fajardo et al.23,a | 50 | 2 | 29 | >50% = 4% at NA |
Katz et al.4,a | 49 | 2 | 29 | >50% = 0% at 24 months |
Lord et al.24,a | 47 | 2 | NA | NA |
AbuRahma et al.15,a | 134 | 1 | 30 | >50% = 2% at 36 months |
AbuRahma et al.19,a | 100 | 0 | 26 | >70% = 0% at 36 months |
Bovine | ||||
Hines et al.25 | 61 | 0 | 13 | >50% = 4.4% at 12 months |
Grimsley et al.26 | 129 | 0 | 41 | >70% = 2% at 41 months |
Ho et al.27 | 457 | 2.2 | 46 | >75% = 1 % at 60 months |
Ladowski et al.20 | 845 | <1 | 19 | >60% = 7.4% at 13 months |
Kim et al.28 | 252 | 2 | 62 | >50% = 2.8% at 62 months |
Marien et al.21,a | 51 | 2 | NA | >60% = 5% at NA |
Bisdas et al.29 | 143 | 2.1 | 1 | NA |
Biasi et al.30 | 323 | 1.5 | NA | >60% = 10% at 60 months |
Matsagas et al.31 | 148 | 1.4 | 20 | >50% = 2% at 36 months |
Neuhauser et al.32 | 59 | 0 | 12 | >70% = 1.6% at 18 months |
Mean F/u = follow-up in months.
Randomized trials.